Can a blood test help diagnose ALS?
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at whether a protein in the blood, called neurofilaments, can help doctors diagnose amyotrophic lateral sclerosis (ALS) more accurately. If you have symptoms that might be ALS, a simple blood test taken during your regular care could help provide answers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are able to have blood drawn (part of standard exams).
- A doctor suspects you may have ALS.
- You have not had a recent stroke.
- You are not pregnant or breastfeeding.
- You are not currently enrolled in another study with an active exclusion period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for new ways to detect and understand ALS by analyzing tiny nerve and blood markers. It may help find better treatments for ALS and related nerve diseases.
This study collects samples (blood, skin, urine) from people with ALS to create cell banks and find biomarkers. It helps researchers learn more about the disease and may lead to better treatments.
This study looks for early signs of ALS in people with genetic risk, healthy controls, and people with early symptoms. It aims to find markers that could help diagnose ALS sooner.
This study looks at blood platelets (tiny cells that help with clotting) in people with ALS and other motor neuron diseases. It aims to find new markers that could help diagnose ALS earlier. If you have a recent diagnosis, you may be able to join by giving a blood sample.
This trial collects blood and spinal fluid samples from people being checked for ALS. The goal is to find clues (biomarkers) in tiny particles from nerve cells that could help doctors better understand and diagnose ALS.
This study measures how well your nerves and muscles work together to see if it can serve as an early sign (a “biomarker”) of ALS. It may help doctors track ALS more accurately, especially in people who already seem to have ALS based on nerve testing.
Hear when a new Neurodegenerative Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.